Skip to content


Delivering Value to Investors

A global leader in DNA sequencing and array-based technologies, Illumina is fueling advancements in life sciences, oncology, reproductive health, genetic disease, agriculture, microbiology, and other emerging segments. We are dedicated to improving human health by unlocking the power of the genome. That mission is behind everything we do, from enabling breakthroughs that move us closer to the realization of precision medicine to delivering value to our investors.

Investor Events
March 13, 2019 | 11:15 ET
Barclays Global Healthcare Conference 2019
January 29, 2019 | 17:00 ET
Q4 & Fiscal Year 2018 Illumina, Inc. Earnings Conference Call
January 7, 2019 | 15:30 PT
J.P. Morgan Healthcare Conference Q&A Session
View All Events & Presentations